This inventor holds 16 USPTO granted patents and 3 published patent applications, plus 6 CIPO patents and 7 EPO patents. Top assignee: Bavarian Nordic A/s. Active years: 2011-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2023
Title: **Hubertus Hochrein: Innovator in Cancer Treatment**
Introduction
Hubertus Hochrein is a distinguished inventor based in Munich, Germany, renowned for his contributions to the field of cancer treatment. With an impressive portfolio of 16 patents, he has made significant strides in the development of innovative therapies that address critical health challenges.
Latest Patents
His latest patents include groundbreaking inventions aimed at enhancing cancer treatment. One notable patent describes a **combination therapy for treating cancer with an antibody and intravenous administration of a recombinant MVA**. This invention focuses on a pharmaceutical combination designed to reduce tumor volume and increase the survival rates of cancer patients. It involves administering a recombinant Modified Vaccinia Ankara (MVA) encoding a tumor-associated antigen and an antibody directly to the patient.
Another significant patent involves a **multivalent recombinant modified vaccinia virus Ankara (MVA) vector encoding filovirus immunogens**. This invention presents an improved vaccine against filovirus infections, specifically targeting the Marburg and Ebola viruses. The recombinant MVA-based vaccine comprises genetically engineered vectors designed to induce a robust immune response, enhancing the efficacy of treatment regimens.
Career Highlights
Hubertus Hochrein works at Bavarian Nordic A/S, a company dedicated to the advancement of innovative vaccines and therapeutics. His work is instrumental in pushing the boundaries of cancer research and vaccine development, showcasing his expertise and commitment to improving public health outcomes.
Collaborations
Throughout his career, Hochrein has collaborated with notable colleagues, including Meredith O'Keeffe and Henning Lauterbach. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and innovative approaches to tackling complex health issues.
Conclusion
In summary, Hubertus Hochrein stands out as a prominent inventor whose work is paving the way for advancements in cancer treatment and vaccination strategies. With his extensive patent portfolio and collaborative efforts, he continues to make a lasting impact on the medical field and inspires future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile